Chronic myelogenous leukemia (CML), results from a balanced translocation t(9;22)(q34;q11.2) giving rise to the BCR-ABL1 chimeric gene being the oncogenic driver of CML [1]. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.